SCHEMBL7140225

SCHEMBL7140225

CNS(=O)(=O)c1ccc2c(c1)C(=Cc1ccc(OC)c(F)c1)C(=O)N2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 1/20 0.53
FCER2 P06734 1/20 0.53
SYK P43405 1/20 0.53
NTRK3 Q16288 1/20 0.53
NTRK2 Q16620 1/20 0.53
SRC P12931 2/20 0.51
PSEN1 P49768 2/20 0.51
PSEN2 P49810 2/20 0.51
APH1B Q8WW43 2/20 0.51
NCSTN Q92542 2/20 0.51
APH1A Q96BI3 2/20 0.51
PSENEN Q9NZ42 2/20 0.51
CDK2 P24941 4/20 0.49
ERBB2 P04626 2/20 0.49
EGFR P00533 1/20 0.49
KDR P35968 1/20 0.48
NOX4 Q9NPH5 1/20 0.47
RET P07949 3/20 0.46
CCNE1 P24864 2/20 0.45
CCNE2 O96020 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5359504 0.91 PSEN1 (0.56) NTRK1FCER2SYKNTRK3NTRK2
SCHEMBL7138911 0.89 NTRK1 (0.54) NTRK1FCER2SYKNTRK3NTRK2
SCHEMBL7135541 0.88 SRC (0.55) NTRK1FCER2SYKNTRK3NTRK2
SCHEMBL7139502 0.88 NOX4 (0.54) NTRK1FCER2SYKNTRK3NTRK2
SCHEMBL5367619 0.86 ERBB2 (0.68) NTRK1FCER2SYKNTRK3NTRK2
SCHEMBL5362923 0.85 PSEN1 (0.54) NTRK1FCER2SYKNTRK3NTRK2
SCHEMBL7132861 0.84 MEN1 (0.54) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5367766 0.84 GSK3B (0.61) NTRK1FCER2SYKNTRK3NTRK2
SCHEMBL5361448 0.84 SYK (0.65) NTRK1FCER2SYKNTRK3NTRK2
SCHEMBL5363360 0.82 SYK (0.62) NTRK1FCER2SYKNTRK3NTRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506763-B2 Useful in prevention and treatment of protein kinase related disorders such as cancer SUGEN, INC. 2003-01-14 US disclosed